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We investigated the impacts of sarA and agr on fnbA expression and fibronectin-binding capacity in Staphylococcus aureus in vitro and in experimental endocarditis. Although sarA up-regulated and agr down-regulated
both fnbA expression and fibronectin binding in vitro and in vivo, fnbA expression was positively regulated in
the absence of both global regulators. Thus, additional regulatory loci contribute to fnbA regulation and
fibronectin-binding capacities in S. aureus.
fnbA promoter expression, employing a promoter-green fluorescent protein (GFP) reporter fusion, as previously described
(28, 30). As expected, fnbA promoter expression was maximal
during exponential growth of the parental strain and then
plateaued (Fig. 1). In addition, the anticipated positive and
negative regulatory effects of sarA and agr, respectively, on
fnbA promoter expression were observed (Fig. 1) (3, 24, 29).
Interestingly, the percentage of fnbA-expressing cells in the
sarA agr double mutant paralleled that of the sarA single
knockout mutant during exponential and early postexponential
growth phases but increased to near-parental levels in late
stationary growth phase (Fig. 1). These data suggest that environmental cues (e.g., low pH, nutrient limitation) or other
regulatory loci contribute to fnbA expression during the stationary growth phase in the absence of sarA and agr in vitro
(e.g., sae) (27).
Northern blot analysis of fnbA transcription. RNA isolation
and Northern blot analysis were performed as described previously (29). The transcription of fnbA in the parental strain
was maximal during mid-log phase (Fig. 2). As expected, in the
agr mutant, there was substantial up-regulation in fnbA transcription during the late log phase, while fnbA transcription in
the sarA mutant was markedly reduced compared to that in the
parental strain (Fig. 2) (24, 29). It is noteworthy that the level
of fnbA transcription in the sarA agr double mutant was between the levels of the single agr and sarA mutants. Interestingly, we also observed a bimodal increase in fnbA transcription in the double mutant, with the first peak occurring during
the mid-log phase and a smaller but noticeable peak occurring
during the late stationary phase (overnight culture). Therefore,
these in vitro transcriptional data concurred with those of the
GFP reporter gene fusion data sets above.
Protease activity in vitro. To quantify overall protease activity, a microplate assay kit (Molecular Probes, Eugene,
Oreg.) was utilized as previously described (4). Protease activ-

Staphylococcus aureus is the most common cause of endovascular infections (2). The capacity of S. aureus to cause
human diseases involves a variety of cell surface-associated and
extracellular virulence factors (5, 7, 11, 15). Two fibronectinbinding proteins (FnBPA and FnBPB), have been ascribed
multiple functions, including cell-specific binding (e.g., epithelial and endothelial cells), invasion and persistence within such
cells, and triggering of host cell apoptosis (1, 14, 21, 26). Additionally, FnBPA has been shown to be involved in adherence
to damaged heart valves (23). Moreover, FnBPs expressed on
the S. aureus surface may be degraded by extracellular proteases (17, 18), suggesting that such enzymes participate in the
transition of S. aureus cells from an adhesive to invasive phenotype.
Classically, the expression of FnBPs and the synthesis of
extracellular proteases are controlled in vitro by at least two
global regulatory loci: the accessory gene regulator (agr) and
the staphylococcal accessory regulator (sarA) in S. aureus (3,
22, 24). There is a complex interaction between sarA and agr to
coordinately regulate S. aureus virulence factor expression,
including selected adhesins and extracellular proteases (7, 9,
22). In the present study, we have characterized the impacts of
the sarA and agr loci upon fnbA expression, fibronectin-binding
capacity, and protease activity in a set of isogenic S. aureus
Newman strains in vitro and in an experimental rabbit endocarditis model.
fnbA promoter expression in vitro. The S. aureus strains and
plasmids used in this study are listed in Table 1 (strain Newman is agr type 1). Flow cytometry (FACScalibur; BectonDickinson, San Jose, Calif.) was utilized for quantification of
* Corresponding author. Mailing address: Division of Infectious
Diseases, St. John’s Cardiovascular Research Center, Harbor-UCLA
Research and Education Institute, 1124 W. Carson St., Torrance, CA
90502. Phone: (310) 222-6422. Fax: (310) 782-2016. E-mail:
bayer@humc.edu.
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TABLE 1. S. aureus strains and plasmids used in this study
Strain or plasmid

Description

Reference

Strains
Newman
ALC637
ALC355
ALC638
ALC1829
ALC1827
ALC1825
ALC1835
ALC1838
ALC1645

Wild type
Newman, sarA::Tn917LTV1
Newman ⌬agr::tetM
Newman ⌬agr::tetM sarA::Tn917LTV1
Newman with recombinant pALC1484
Newman with recombinant pALC1484 containing the fnbA promoter
ALC637 with recombinant pALC1484 containing the fnbA promoter
ALC355 with recombinant pLAC1484 containing the fnbA promoter
ALC638 with recombinant pALC1484 containing the fnbA promoter
RN6390 with ⌬spa::Etbr mutation

29
29
29
29
This work
29
29
29
29
30

Plasmid
pALC1484

pSK236 with a promoterless gfpuvr gene

29

ity was slightly decreased in the agr mutant (⬃0.8-fold) but
significantly increased in the sarA mutant (three- to fivefold; P
⬍ 0.05) compared to the parental strain (Fig. 3). These data
are consistent with the documented repression of protease
production by sarA (17, 18). The sarA agr double mutant had a
quantitative protease phenotype that was intermediate between those of the sarA and agr single mutants. No protease
activity was observed from any study strain after 4 h of incubation (data not shown).
To evaluate the effect of the global protease inhibitor, ␣2macroglobulin (Boehringer-Mannheim, San Diego, Calif.), the
above experiments were repeated with cultures preexposed to
the inhibitor (range, 0.4 to 1.6 U/ml). Protease activity was
inhibited (⬎80% for all study strains) in the presence of ␣2macroglobulin (1.2 U/ml) (data not shown).
Fibronectin adherence in vitro. To quantitate correlation
between fnbA expression and fibronectin adherence phenotypes, we evaluated the fibronectin-binding capacities of S.
aureus by direct binding to immobilized human fibronectin as
previously described (17, 19). It is noteworthy that fibronectin-

FIG. 1. Expression of the fnbA promoter in the parental and mutant strains in vitro. The percentage of GFP-positive S. aureus cells
during 24 h of incubation in vitro is shown for the fnbA::gfpuvr parental
strain (■), agr mutant (Œ), sarA mutant (}), sarA agr double mutant
(F), and promoterless gfpuvr strain ({).

binding properties of the set of strains paralleled the individual
fnbA promoter expression profiles of the strains in vitro (Fig.
4). For example, fibronectin binding was higher in the agr
mutant than in the parental strain, but it was lower in the sarA
mutant (binding of the parental strain to fibronectin reached
⬃5% of the inoculum after 24 h of incubation). In addition, the
fibronectin-binding capacity of the sarA agr double mutant
exceeded that of the sarA mutant during the stationary growth
phase (16 to 24 h).
Since the production of proteases is down-regulated in the
agr mutant but up-regulated in the sarA mutant and since
FnBPs can be degraded by such proteases, it was conceivable
that alterations in fibronectin-binding phenotypes might be
related to variations in their individual protease production
profiles. To test this hypothesis, all study strains were preexposed to ␣2-macroglobulin (1.2 U/ml), and the fibronectin
adherence properties were then determined. For all study
strains grown in the presence of ␣2-macroglobulin, there was a
ⱖ30% increase in fibronectin-binding activities throughout the
growth cycle compared to strains grown in the absence of the
inhibitor. These data suggest that extracellular protease production contributes modestly to the overall fibronectin-binding
capacity of S. aureus strains. However, the fact that all strains
were equally affected by protease inhibition and only to a
modest extent indicates that the predominant mechanisms dictating phenotypic fibronectin binding probably occur at the
level of fnbA transcription.
Experimental rabbit endocarditis model. Recent studies
have demonstrated that S. aureus virulence gene regulation
profiles defined in vitro are often not precisely mirrored in vivo
(6, 8, 28, 30). These data imply that host environmental cues
play a major role in the activation of key S. aureus virulence
genes. Thus, we sought to correlate fnbA promoter activation
profiles defined in vitro with those delineated in experimental
rabbit endocarditis. A well-characterized rabbit endocarditis
model was used in these studies as previously described (28,
30).
(i) Microbiologic evaluation. S. aureus densities achieved in
vegetations were significantly higher than in kidney and spleen
for all study constructs at 48 h postinfection (P ⬍ 0.05) (Table
2). In addition, all the mutants had lower target tissue bacterial
densities than the parental strain, although these differences
did not reach statistical significance. By comparison, S. aureus
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FIG. 2. Northern blots of fnbA transcripts from the wild-type (wt) Newman strain and its isogenic agr, sarA, and sarA agr double mutants. RNAs
were harvested from mid-log phase (lanes 1 and 2), late log phase (lane 3), early stationary phase (lane 4), and late stationary phase (lanes 5 and
6). We have included transcription of 16S rRNA as a loading control.

densities in vegetations were comparable in all study strains at
8 h postinfection (data not shown).
(ii) fnbA promoter expression in vivo. Flow cytometry and a
protein A-based immunodetection system were used for detection of fnbA promoter expression in the endocarditis model
as previously detailed (28, 30). Interestingly, fnbA promoter
expression profiles defined in vivo in all target tissues for the
various constructs paralleled in vitro fnbA expression profiles
(Fig. 5). Compared to the parental cells, we observed increased
fnbA expression in the agr mutant and decreased fnbA expression in the sarA mutant, with expression in the double mutant
being greater than that of the sarA mutant in all target tissues
(Fig. 5) (P ⬍ 0.05 for the parent versus the agr mutant in
vegetations at 48 h). As in prior studies (28, 30), there were
target tissue-specific differences in gene expression, with maximal fnbA expression seen in vegetations and kidneys, with
reduced expression in the spleen. It is interesting that the
extent of GFP expression for the various constructs paralleled

the percentage of GFP expression in the target tissues studied
(data not shown).
(iii) Fibronectin adherence ex vivo. To determine the relative ability of the study strains (obtained directly from vegetations) to adhere to fibronectin, a modification of the above in
vitro adherence assay was performed. Briefly, S. aureus cells
(⬃5 ⫻ 103 CFU based on anticipated vegetation densities)
from each vegetation sample (at 24 h after infection [107 CFU/
animal]) were directly assessed ex vivo for fibronectin-binding
capacity by the in vitro assay detailed above. The in vivo fnbA
expression profiles noted above roughly paralleled the fibronectin-binding capacities of the various constructs isolated
directly from cardiac vegetations (data not shown). For example, compared to parental cells, the agr mutant cells adhered
slightly more to fibronectin, but the sarA mutant adhered significantly less to fibronectin (P ⬍ 0.05). Remarkably, the sarA
agr double mutant adhered to fibronectin to a higher extent
than the sarA single mutant (P ⬍ 0.05 for sarA single mutant

FIG. 3. Protease activity in S. aureus fnbA::gfpuvr in the parental
strain (䊐) and agr (d), sarA (s), and sarA agr (■) mutants during 24 h
of incubation in vitro. The total protease activity in sarA and/or agr
mutants is shown as the percent activity relative to that of the corresponding parent strain, which was normalized at 100%.

FIG. 4. Adherence of S. aureus Newman fnbA::gfpuvr in agr (䊐),
sarA (s), and sarA agr (■) mutants to fibronectin versus the parental
strain in vitro. The results are presented as the mean percentage (⫾
standard deviation [error bar]) fibronectin binding compared to that of
the parental strain.
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TABLE 2. S. aureus fnbA::gfpuvr Newman parental strain and its
isogenic agr and/or sarA mutant densities in target tissues of animals
with endocarditis challenged with 107 CFU/animal
Strain
(no. of rabbits)

Parental (10)
agr mutant (12)
sarA mutant (10)
sarA agr double
mutant (10)
a

Log10 CFU/g of tissue (mean ⫾ SD)
Vegetation

8.62 ⫾ 0.32
8.30 ⫾ 0.37
7.95 ⫾ 0.88
7.87 ⫾ 0.52

Kidney

Spleen
a

7.67 ⫾ 0.42
7.06 ⫾ 0.80a
6.72 ⫾ 1.19a
6.66 ⫾ 0.87a

6.62 ⫾ 0.56a
6.11 ⫾ 0.55a
5.62 ⫾ 0.75a
5.89 ⫾ 0.46a

Significantly different from the value obtained for vegetation (P ⬍ 0.05).

versus parental strain), mirroring the in vitro and in vivo (intravegetation) profiles of fnbA expression.
Several interesting observations emanated from this investigation. As expected, fnbA promoter expression in vitro was
maximal during exponential growth of the parental strain and
then plateaued. In addition, using single knockout mutants, the
anticipated positive and negative regulatory effects of sarA and
agr, respectively, on fnbA promoter expression in vitro were
confirmed (3, 24, 29). Surprisingly, the extent of fnbA promoter
expression in the sarA agr double mutant paralleled that of the
sarA single knockout mutant during exponential and early postexponential growth phases but increased to near-parental levels in late stationary growth phase. Similarly, utilizing Northern
blot analysis, Blevins et al. (3) noted fnbA transcription in sarA
agr double mutants to be at or above the levels observed for the
sarA single mutants in two clinical S. aureus strains. Collectively, these data suggest that during the stationary growth
phase, environmental cues (e.g., low pH, nutrient limitation) or
other regulatory loci that influence fnbA expression contribute
to fnbA regulation in the absence of sarA and agr in vitro (e.g.,
the sae regulon seems to be required for fnbA activation in the
Newman strain [27]). Further, delineation of the regulatory
functions of the growing family of sarA homologs may also
yield relevant information in this context (10, 12, 20, 25).
To correlate the above differences in fnbA expression pro-
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files in vitro with a key functional phenotype, we compared the
temporal fibronectin-binding capacities of this set of strains. It
is noteworthy that the growth phase-related fibronectin-binding properties of this set of strains in our solid-phase assay
paralleled their individual fnbA promoter expression profiles in
vitro (results which are consistent with those reported by
Blevins et al. [3], who utilized a liquid-phase fibronectin-binding assay). As with our sarA agr double mutant, in six of the
seven strains Blevins et al. (3) studied (including the Newman
strain), the fibronectin-binding capacity of the sarA agr double
mutant exceeded that of the sarA single mutant by as much as
twofold. Importantly, fnbA promoter expression profiles and
fibronectin-binding phenotypes defined in vitro for the various
constructs in the current study roughly paralleled the profiles
and phenotypes defined in vivo in all target tissues in early and
well-established infections.
It has been reported that sarA and agr mediate their effects
on fnbA at the transcriptional level; this same regulatory pattern has been demonstrated in the Newman strain by Western
blot analysis (29). These data indicate that the fibronectinbinding activities of S. aureus strains are at least partially due
to direct regulation of fnbA transcription by sarA and agr.
However, the overall S. aureus fibronectin-binding capacity is
likely multifactorial, including extracellular protease production as well as production of a cadre of other FnBPs (e.g.,
FnbB, Ebh [host extracellular matrix binding protein homologue], and Emp [extracellular matrix protein binding protein])
(13, 16). Taken together, it is likely that the collective fibronectin-binding capacity of a given S. aureus strain reflects a composite of the activation and regulation of these various loci.
Future studies will be required to evaluate the in vitro and in
vivo expression paradigms of these other FnBPs, using animal
models and gene reporter systems similar to those used in this
study, to determine their relative contributions to net fibronectin binding in vitro and in vivo.
This work was supported in part by grants from the American Heart
Association to Y.-Q.X. (0265054Y) and the National Institutes of

FIG. 5. S. aureus fnbA promoter expression in vegetation, kidney, and spleen during the course of experimental endocarditis. (A) Percent
GFP-positive S. aureus cells in vegetations at 8 and 48 h infection. (B) Percent GFP-positive S. aureus cells in kidney and spleen at 48 h infection.
Symbols: 䊐, parental strain; d, agr mutant; s, sarA mutant; ■, sarA agr double mutant.
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